Number of the records: 1
Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway
SYS 0184394 LBL 00000naa^^22^^^^^^^^450 005 20221213115558.0 100 $a 20221114d2022 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway $f Min Yuan ... [et al.] 215 $c ilustr., aj fareb., grafy, obr. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0184350 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 69, no. 4 (2022), s. 807-819 $1 210 $a Bratislava $c AEPress $d 2022 $1 215 $a s. 747-993 606 1-
$3 sllk_un_auth*d013274 $a nádory žalúdka $2 mesh 606 1-
$3 sllk_un_auth*d011505 $a proteíntyrozínkinázy $x antagonisty a inhibítory $2 mesh 606 1-
$3 sllk_un_auth*d060890 $a antigén B7-H1 $2 mesh 606 2-
$3 sllk_un_auth*d009385 $a procesy nádorové $2 mesh 606 2-
$3 sllk_un_auth*d045744 $a línia bunková nádorová $2 mesh 606 2-
$3 sllk_un_auth*d023041 $a testy protinádorového účinku na xenoimplantátových modeloch $2 mesh 610 2-
$a anlotinib - použitie terapeutické 610 2-
$a expresia PD-L1 610 2-
$a štúdia experimentálna 701 -1
$3 sllk_un_auth*0056971 $a Yuan $b Min $4 070 801 -0
$a SK $b BA006 $c 20221114 $g AACR2
Number of the records: 1